DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 215 filers reported holding DENALI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,393,889 | -29.3% | 103,096 | -37.5% | 0.01% | 0.0% |
Q1 2024 | $3,387,339 | +15.6% | 165,075 | +20.8% | 0.01% | 0.0% |
Q4 2023 | $2,931,436 | +32.7% | 136,600 | +27.6% | 0.01% | +25.0% |
Q3 2023 | $2,209,246 | -4.3% | 107,089 | +36.8% | 0.01% | 0.0% |
Q2 2023 | $2,309,246 | +28.1% | 78,253 | 0.0% | 0.01% | +33.3% |
Q1 2023 | $1,802,949 | -17.2% | 78,253 | 0.0% | 0.01% | -25.0% |
Q4 2022 | $2,176,216 | -9.4% | 78,253 | 0.0% | 0.01% | -20.0% |
Q3 2022 | $2,402,000 | -11.2% | 78,253 | -14.8% | 0.01% | 0.0% |
Q2 2022 | $2,705,000 | +9.3% | 91,898 | +19.5% | 0.01% | +25.0% |
Q1 2022 | $2,475,000 | -6.9% | 76,931 | +29.0% | 0.01% | 0.0% |
Q4 2021 | $2,659,000 | -3.0% | 59,618 | +9.8% | 0.01% | 0.0% |
Q3 2021 | $2,740,000 | -31.3% | 54,308 | +6.8% | 0.01% | -38.5% |
Q2 2021 | $3,989,000 | +41.8% | 50,860 | +3.2% | 0.01% | +30.0% |
Q1 2021 | $2,813,000 | -40.0% | 49,271 | -12.1% | 0.01% | -41.2% |
Q4 2020 | $4,692,000 | +81.5% | 56,023 | -22.4% | 0.02% | +70.0% |
Q3 2020 | $2,585,000 | +27.5% | 72,159 | -14.0% | 0.01% | +25.0% |
Q2 2020 | $2,028,000 | – | 83,876 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,705,039 | $343,645,000 | 25.68% |
Casdin Capital, LLC | 1,500,000 | $66,900,000 | 1.89% |
Flagship Pioneering Inc. | 2,619,968 | $116,851,000 | 1.81% |
SECTORAL ASSET MANAGEMENT INC | 189,600 | $8,456,000 | 1.27% |
Integral Health Asset Management, LLC | 100,000 | $4,460,000 | 1.23% |
Temasek Holdings (Private) Ltd | 5,369,487 | $239,479,000 | 0.86% |
Goldstream Capital Management Ltd | 78,418 | $3,497,000 | 0.86% |
Yiheng Capital Management, L.P. | 335,184 | $14,949,000 | 0.76% |
GILDER GAGNON HOWE & CO LLC | 2,900,114 | $129,345,000 | 0.74% |
Artal Group S.A. | 600,000 | $26,760,000 | 0.73% |